A detailed history of Lpl Financial LLC transactions in Argenx Se stock. As of the latest transaction made, Lpl Financial LLC holds 7,646 shares of ARGX stock, worth $4.77 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,646
Previous 3,401 124.82%
Holding current value
$4.77 Million
Previous $1.46 Million 183.58%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$434.22 - $551.9 $1.84 Million - $2.34 Million
4,245 Added 124.82%
7,646 $4.15 Million
Q2 2024

Aug 07, 2024

BUY
$356.01 - $451.55 $72,270 - $91,664
203 Added 6.35%
3,401 $1.46 Million
Q1 2024

May 10, 2024

BUY
$356.95 - $413.29 $147,063 - $170,275
412 Added 14.79%
3,198 $1.26 Million
Q4 2023

Feb 14, 2024

BUY
$338.91 - $506.01 $289,768 - $432,638
855 Added 44.28%
2,786 $1.06 Million
Q3 2023

Nov 13, 2023

BUY
$369.35 - $548.43 $713,214 - $1.06 Million
1,931 New
1,931 $949,000
Q1 2022

May 16, 2022

SELL
$254.45 - $351.06 $152,670 - $210,636
-600 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$272.01 - $353.03 $37,265 - $48,365
-137 Reduced 18.59%
600 $210,000
Q3 2021

Nov 15, 2021

BUY
$295.0 - $350.58 $217,415 - $258,377
737 New
737 $223,000

Others Institutions Holding ARGX

About ARGENX SE


  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $34.5B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Lpl Financial LLC Portfolio

Follow Lpl Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.